A novel biomarker for chemotherapy-associated venous thromboembolism
Ovarian cancer patients are at high risk of venous thromboembolism (VTE). More than 80% of women present with a...
Most Read
Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients
Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
PODCAST. Thrombosis and coagulation in the contemporary management of breast cancer. Waiting for ICTHIC 2022
Breast cancer is the most commonly diagnosed cancer in women accounting for a quarter of cancer cases worldwide. This...
Developmental hemostasis and its relevance to pediatric thrombosis
The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in...
An interview with Raffaella Giavazzi
Raffaella Giavazzi during her 5th Simon Karpatkin Memorial Lecture at the 9th ICTHIC in...
Long-term cancer survivors: a growing population at risk
Continued rapid advancement in cancer treatment and early cancer detection have resulted in a steady growth of the...
Development, evaluation, and validation of an innovative electronic clinical risk prediction model for CAT
Thromboprophylaxis remains a critical concern in cancer patients initiating chemotherapy due to their heightened risk...
Coagulopathy and thrombosis in COVID-19 patients: parameters to be checked to assess disease severity
As the clinical evidence keeps on accumulating, we can clearly state that coronavirus disease 2019 (COVID-19) very...
PODCAST. Building a CAT Clinic: Real-World Systems Approaches to Prevention and Treatment. Waiting for ICTHIC 2022
Cancer-associated thrombosis (CAT) is an important and increasingly common complication of cancer and cancer...
Risk stratification of PE in the cancer patient
During the ICTHIC webinar titled “Management of CAT: Lung Cancer Focus,” Professor António Araújo...